Notification
No new Notification messages
Niva Bupa Health Insurance IPO is Open!
Apply for the Niva Bupa Health Insurance IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
unihealth consultancy ltd stock

UNIHEALTH CONSULTANCY LTD Share Price

165.5 -3.50 (-2.07%)
Nov 08 2024 03:29 PM Healthcare NSE: UNIHEALTH

UNIHEALTH CONSULTANCY LTD Share Price Update

As of the latest trading session, UNIHEALTH CONSULTANCY LTD share price is currently at 165.5, which is down by -3.50 from its previous closing. Today, the stock has fluctuated between 162.00 and 178.00. Over the past year, UNIHEALTH CONSULTANCY LTD has achieved a return of 26.20 %. In the last month alone, the return has been 12.22 %. Read More...

UNIHEALTH CONSULTANCY LTD Performance

Day Range

Low162.00 High178.00
170.25

52 Week Range

Low 109.00 High 178.00
170.25

UNIHEALTH CONSULTANCY LTD Share Price

18582

UNIHEALTH

img img img img
No Data Available

Open Price

165.60

Prev. Close

169.00

Volume (Shares)

61000.00

Total traded value

103.85

Upper Circuit

202.80

Lower Circuit

135.20

Note: The current prices & values are delayed, Login to your account for live updates.

UNIHEALTH CONSULTANCY LTD Fundamentals


(Standalone)

Market Cap (Cr) 254.86
PE Ratio (TTM) 86.42
Book Value / Share 41.86
Beta 0.57
ROE 7.67%
EPS (TTM) 1.97
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

UNIHEALTH CONSULTANCY LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 4.23
Operating Expense 2.77
Net Profit 3.04
Net Profit Margin (%) 71.86
Earnings Per Share (EPS) 2.26
EBITDA 4.29
Effective Tax Rate (%) 19.78
Particulars MAR 2023 (Values in Cr)
Revenue 1.92
Operating Expense 2.59
Net Profit 1.34
Net Profit Margin (%) 69.79
Earnings Per Share (EPS) 9.96
EBITDA 2.34
Effective Tax Rate (%) -19.81
Particulars MAR 2022 (Values in Cr)
Revenue 1.61
Operating Expense 2.08
Net Profit 0.48
Net Profit Margin (%) 29.81
Earnings Per Share (EPS) 3.56
EBITDA 1.76
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.63
Operating Expense 1.64
Net Profit -1.16
Net Profit Margin (%) -184.12
Earnings Per Share (EPS) -8.61
EBITDA -0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.49
ROE % 18.39
ROCE % 20.15
Total Debt to Total Equity 0.48
EBITDA Margin 39.30
Particulars MAR 2023 (Values in Cr)
Book Value / Share 198.04
ROE % 32.70
ROCE % 21.28
Total Debt to Total Equity 1.83
EBITDA Margin 35.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 110.23
ROE % 21.63
ROCE % 18.59
Total Debt to Total Equity 3.01
EBITDA Margin 34.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.76
ROE % 46.27
ROCE % 13.41
Total Debt to Total Equity 4.85
EBITDA Margin 34.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 7.16
EBITDA Margin 12.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 41.87
ROE % 7.67
ROCE % 8.69
Total Debt to Total Equity 0.20
EBITDA Margin 101.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.17
ROE % 10.94
ROCE % 9.39
Total Debt to Total Equity 1.22
EBITDA Margin 122.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.54
ROE % 4.92
ROCE % 7.82
Total Debt to Total Equity 1.78
EBITDA Margin 109.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 28.50
Total Assets 110.20
Total Liabilities 110.20
Total Equity 85.20
Share Outstanding 15399952
Price to Book Ratio 3.22
Return on Assets (%) 9.35
Return on Capital (%) 10.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 78.33
Total Liabilities 78.33
Total Equity 27.27
Share Outstanding 1389494
Price to Book Ratio 0.00
Return on Assets (%) 9.80
Return on Capital (%) 11.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 64.78
Total Liabilities 64.78
Total Equity 14.56
Share Outstanding 1341875
Price to Book Ratio 0.00
Return on Assets (%) 5.89
Return on Capital (%) 7.27
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.05
Total Assets 58.38
Total Liabilities 58.38
Total Equity 10.58
Share Outstanding 1341875
Price to Book Ratio 0.00
Return on Assets (%) 8.57
Return on Capital (%) 10.16
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 58.33
Total Liabilities 58.33
Total Equity 5.65
Share Outstanding 1341875
Price to Book Ratio 0.00
Return on Assets (%) -1.45
Return on Capital (%) -1.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 26.64
Total Assets 68.47
Total Liabilities 68.47
Total Equity 64.47
Share Outstanding 15399952
Price to Book Ratio 3.22
Return on Assets (%) 4.43
Return on Capital (%) 4.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 25.35
Total Liabilities 25.35
Total Equity 12.66
Share Outstanding 1389494
Price to Book Ratio 0.00
Return on Assets (%) 5.27
Return on Capital (%) 5.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 18.52
Total Liabilities 18.52
Total Equity 6.51
Share Outstanding 1341875
Price to Book Ratio 0.00
Return on Assets (%) 2.57
Return on Capital (%) 2.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 16.65
Total Liabilities 16.65
Total Equity 6.03
Share Outstanding 1341875
Price to Book Ratio 0.00
Return on Assets (%) -6.93
Return on Capital (%) -9.07
Particulars MAR 2024 (Values in Cr)
Net Income 13.64
Cash from Operations 7.09
Cash from Investing -2.41
Cash from Financing 21.55
Net change in Cash 23.70
Free Cash Flow 9.47
Particulars MAR 2023 (Values in Cr)
Net Income 9.27
Cash from Operations 2.95
Cash from Investing -4.91
Cash from Financing 3.34
Net change in Cash -0.24
Free Cash Flow 5.27
Particulars MAR 2022 (Values in Cr)
Net Income 5.20
Cash from Operations 9.34
Cash from Investing -0.94
Cash from Financing -5.88
Net change in Cash 2.51
Free Cash Flow 10.64
Particulars MAR 2021 (Values in Cr)
Net Income 5.47
Cash from Operations 4.05
Cash from Investing -0.35
Cash from Financing -3.25
Net change in Cash 0.44
Free Cash Flow 4.41
Particulars MAR 2020 (Values in Cr)
Net Income -0.91
Cash from Operations 0.67
Cash from Investing -1.89
Cash from Financing 1.19
Net change in Cash -0.04
Free Cash Flow 3.20
Particulars MAR 2024 (Values in Cr)
Net Income 3.78
Cash from Operations -1.92
Cash from Investing -10.50
Cash from Financing 39.57
Net change in Cash 26.60
Free Cash Flow -0.10
Particulars MAR 2023 (Values in Cr)
Net Income 1.11
Cash from Operations 1.97
Cash from Investing -7.17
Cash from Financing 5.08
Net change in Cash -0.11
Free Cash Flow 1.97
Particulars MAR 2022 (Values in Cr)
Net Income 0.47
Cash from Operations -0.83
Cash from Investing 0.72
Cash from Financing 0.15
Net change in Cash 0.04
Free Cash Flow -0.83
Particulars MAR 2021 (Values in Cr)
Net Income -1.15
Cash from Operations -0.32
Cash from Investing 0.06
Cash from Financing 0.18
Net change in Cash -0.07
Free Cash Flow -0.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 90.19 14.23 106701.16 5122.60 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.59 0.00 3.36 100.44 44.00 / 107.94
SHREE PACETRONIX LTD. 130.00 20.93 3.48 46.79 118.00 / 368.70
TRANSGENE BIOTEK LTD. 6.55 0.00 4.63 49.63 5.38 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 95.02 13.02 106701.16 5122.60 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 39.07 0.00 -89.41 29.19 26.57 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5596.20 31.49 6.89 6122.24 2575.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 169.20
  • 26 Days 160.40
  • 10 Days 164.80
  • 50 Days 157.70
  • 12 Days 164.40
  • 100 Days 145.70
  • 20 Days 162.30
  • 200 Days 144.00
168.00
PIVOT
First Resistance 171.00
Second Resistance 173.00
Third Resistance 176.00
First Support 166.00
Second Support 163.00
Third Support 161.00
RSI 64.09
MACD 3.99
Commodity Channel Index (CCI) 117.25
ADX 33.92
Williams % R -19.90

Over 1 Month

down

12.22

Over 3 Months

down

44.83

Over 6 Months

down

41.22

Over 1 Year

down

26.20

Over 3 Years

down

0.00

Over 5 Years

down

0.00

UNIHEALTH CONSULTANCY LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

UNIHEALTH CONSULTANCY LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
31.19
Promoter Holdings
68.8
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Anurag Ratankumar Shah Shareholding of Promoter and Promoter Group 5000000.0 32.47
Akshay Mahendra Parmar Shareholding of Promoter and Promoter Group 4180000.0 27.14
Prafulla Mahendra Parmar Shareholding of Promoter and Promoter Group 819960.0 5.32
Niraj Rajnikant Shah Public Shareholding 636000.0 4.13
Anant Wealth Consultants Public Shareholding 469000.0 3.05
Shantilal Bhikchand Kataria Shareholding of Promoter and Promoter Group 381152.0 2.48
Sangeeta Shah Shareholding of Promoter and Promoter Group 138000.0 0.9
Mayuri Akshay Parmar Shareholding of Promoter and Promoter Group 76800.0 0.5

UNIHEALTH CONSULTANCY LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About UNIHEALTH CONSULTANCY LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by UNIHEALTH CONSULTANCY LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Unihealth Consultancy Ltd?

Answer Field

The share price of Unihealth Consultancy Ltd for NSE is ₹ 165.5 and for BSE is ₹ 0.00.

What is the Market Cap of Unihealth Consultancy Ltd?

Answer Field

The market cap of Unihealth Consultancy Ltd for NSE is ₹ 2,54.86 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Unihealth Consultancy Ltd?

Answer Field

The 52 Week High and Low of Unihealth Consultancy Ltd for NSE is ₹ 178.00 and ₹ 109.00 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Unihealth Consultancy Ltd share?

Answer Field

You can trade in Unihealth Consultancy Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Unihealth Consultancy Ltd?

Answer Field

The 1 year returns on the stock has been 26.20%.

What is the Current Share Price of Unihealth Consultancy Ltd?

Answer Field

Unihealth Consultancy Ltd share price is for NSE ₹ 165.5 & for BSE ₹ 0.00 as on Nov 08 2024 03:29 PM.

What is the Market Cap of Unihealth Consultancy Ltd Share?

Answer Field

The market cap of Unihealth Consultancy Ltd for NSE ₹ 2,54.86 & for BSE ₹ 0.0 as on Nov 08 2024 03:29 PM.

What is the P/E Ratio of Unihealth Consultancy Ltd Share?

Answer Field

As on Nov 08 2024 03:29 PM the price-to-earnings (PE) ratio for Unihealth Consultancy Ltd share is 86.42.

What is the PB ratio of Unihealth Consultancy Ltd Share?

Answer Field

As on Nov 08 2024 03:29 PM, the price-to-book (PB) ratio for Unihealth Consultancy Ltd share is 41.86.

How to Buy Unihealth Consultancy Ltd Share?

Answer Field

You can trade in Unihealth Consultancy Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Unihealth Consultancy Ltd Share on Bajaj Broking App?

Answer Field

To buy Unihealth Consultancy Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Unihealth Consultancy Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader